Skip to content

Vestibular Rehabilitation for Unsteadiness After Intratympanic Gentamicin in Patients With Meniere's Disease

The Effect of Vestibular Rehabilitation Treatment (VRT) on Patients With Unsteadiness After Intratympanic Gentamicin in Meniere's Disease: Protocol for a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06143462
Enrollment
48
Registered
2023-11-22
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Disorder

Brief summary

To investigate the efficacy of vestibular rehabilitation treatment on unsteadiness after intratympanic gentamicin in patients with Meniere's disease.

Detailed description

Previous studies have generally focused on the efficacy of VRT for Meniere's disease, with little attention paid to the effect of VRT on MD patients who still have vestibular dysfunction even after intratympanic gentamicin treatment. The aim of this study is to compare the efficacy of VRT with usual care in MD patients who experience persistence of unsteadiness 1 month after intratympanic gentamicin treatment, in order to understand whether VR has a positive impact on balance maintenance and vertigo control in MD patients.

Interventions

DRUGUsual care

Include anti-dizziness medications, diuretics, or hormone therapy.

OTHERHealth Education

Include comprehensive health education, fall prevention and lifestyle adjustments.

BEHAVIORALvestibular rehabilitation

Encompass office-based sessions of vestibular rehabilitation treatment once weekly, supplemented by home-based exercises conducted two or three times daily for the remaining duration of the study.

Sponsors

Eye & ENT Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Adults aged between 18 and 75 years old; 2. Complained of persistent unsteadiness 1 month after intratympanic gentamicin treatment; 3. Be willing to sign the informed consent of the study.

Exclusion criteria

1. Conformed to neuromuscular disease; 2. Conformed to severe cervical spine disease; 3. Conformed to congenital inner ear disease (except vestibular migraine(VM)) 4. Concurrent manifestation of psychiatric or psychological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Functional Gait Assessment (FGA)Change from baseline, at 8 weeks and 6 months post-randomizationFGA is a semi-quantitative measure of walking balance ability.

Secondary

MeasureTime frameDescription
Sensory Organization Test (SOT)Change from baseline, at 8 weeks and 6 months post-randomizationSOT is a form of posturography, aiming to distinguish and assess the weight of vestibular, visual, and proprioceptive sensations in maintaining balance.
Meniere's Disease Outcomes Questionnaire (MDOQ)Change from baseline, at 8 weeks and 6 months post-randomizationMDOQ is a comprehensive assessment of MD patients' quality of life (QOL) in three dimensions: physical, emotional, and social.
Visual Vertigo Analogue Scale (VVAS)Change from baseline, at 8 weeks and 6 months post-randomizationIn VVAS, patients estimate the intensity of their symptoms related to dizziness, vertigo, and imbalance.
Vestibular Activities and Participation Measure (VAP)Change from baseline, at 8 weeks and 6 months post-randomizationVAP is a 34-item self-report questionnaire, aiming to evaluate the extent of activity limitations and participation restrictions created by vestibular disorders.

Countries

China

Contacts

Primary ContactHuiqian Yu
yhq925@163.com13636423139
Backup ContactQiling Tong
23211260026@m.fudan.edu.cn13816520179

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026